M&G Investment Management LTD Catalent, Inc. Transaction History

M&G Investment Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 25, 2022	SELL	$87.2 - $114.05 $1.2 Million - $1.57 Million	-13,749 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$119.57 - $139.07 $14 Million - $16.2 Million	-116,701 Reduced 89.46%	13,749 $1.76 Million
Q3 2021 Nov 09, 2021	BUY	$109.17 - $142.35 $75,436 - $98,363	691 Added 0.53%	130,450 $17.4 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $13 Million - $15 Million	129,759 New	129,759 $14 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on M&G Investment Management LTD with notifications on news.